Diagnostic role of tests for T cell receptor (TCR) genes

Journal of Clinical Pathology

Volumn 56, Issue 1, 2003, Pages 1-11

  Hodges, E ^a   Krishna, M T ^a   Pickard, C ^a   Smith, J L ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; CLONE; DIAGNOSTIC TEST; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SOUTHERN BLOTTING; T LYMPHOCYTE;

BLOTTING, SOUTHERN; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOPROLIFERATIVE DISORDERS; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL;

EID: 0037245626     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.1.1     Document Type: Review

References (139)

1. Clevers H, Alarcon B, Wileman T, et al. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 1988;6:629-62.
2. Rudd CE, Janssen O, Cai YC, et al. Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today 1994;15:225-34.
3. Weiss A, Iwashima M, Irving B, et al. Molecular and genetic insights into T cell antigen receptor signal transduction. Adv Exp Med Biol 1994;365:53-62.
4. Esin S, Shigematsu M, Nagai S, et al. Different percentages of peripheral blood gamma delta + T cells in healthy individuals from different areas of the world. Scand J Immunol 1996;43:593-6.
5. Ciccone E, Ferrini S, Bottino C, et al. A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+. J Exp Med 1988;168:1-11.
6. Dechanet J, Merville P, Lim A, et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 1999;103:1437-49.
7. WHO-IUIS Nomenclature Sub-committee on TCR Designation. Nomenclature for T-cell receptor (TCR) gene segments of the immune system. Immunogenetics 1995;42:451-3.
8. Caccia N, Kronenberg M, Saxe D, et al. The T cell receptor beta chain genes are located on chromosome 6 in mice and chromosome 7 in humans. Cell 1984;37:1091-9.
9. Morton CC, Duby AD, Eddy RL, et al. Genes for beta chain of human T-cell antigen receptor map to regions of chromosomal rearrangement in T cells. Science 1985;228:582-5.
10. Isobe M, Erikson J, Emanuel BS, et al. Location of gene for beta subunit of human T-cell receptor at band 7q35, a region prone to rearrangements in T cells. Science 1985;228:580-2.
11. Griesser H, Champagne E, Tkachuk D, et al. The human T cell receptor alpha-delta locus: a physical map of the variable, joining and constant region genes. Eur J Immunol 1988;4:641-4.
12. Wilson RK, Lai E, Concannon P, et al. Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev 1988;101:149-72.
13. Rabbitts TH, Lefranc MP, Stinson MA, et al. The chromosomal location of T-cell receptor genes and a T cell rearranging gene: possible correlation with specific translocations in human T cell leukaemia. EMBO J 1985;4:1461-5.
14. Lefranc M-P. Locus maps and genomic repertoire of the human T cell repertoire. The Immunologist 2000;8:72-8.
15. Alt FW, Oltz EM, Young F, et al. VDJ recombination. Immunol Today 1992;13:306-14.
16. Roman-Roman S, Ferradini L, Azocar J, et al. Studies on the human T cell receptor alpha/beta variable region genes. I. Identification of 7 additional V alpha subfamilies and 14 J alpha gene segments. Eur J Immunol 1991;21:927-33.
17. Yoshikai Y, Clark SP, Taylor S, et al. Organization and sequences of the variable, joining and constant region genes of the human T-cell receptor alpha-chain. Nature 1985;316:837-40.
18. Kimura N, Toyonaga B, Yoshikai Y, et al. Sequences and repertoire of the human T cell receptor alpha and beta chain variable region genes in thymocytes. Eur J Immunol 1987;17:375-83.
19. Klein MH, Concannon P, Everett M, et al. Diversity and structure of human T-cell receptor alpha-chain variable region genes. Proc Natl Acad Sci U S A 1987;84:6884-8.
20. Koop BF, Hood L. Striking sequence similarity over almost 100 kilobases of human and mouse T-cell receptor DNA. Nat Genet 1994;7:48-53.
21. Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 1996;272:1755-62.
22. Toyonaga B, Mak TW. Genes of the T-cell antigen receptor in normal and malignant T cells. Annu Rev Immunol 1987;5:585-620.
23. Arden B, Clarke SP, Kabelitz D. Human T-cell receptor variable gene segment families. Immunogenetics 1995;42:455-500.
24. Lefranc MP, Forster A, Baer R, et al. Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups. Cell 1986;45:237-46.
25. Forster A, Huck S, Ghanem N, et al. New subgroups in the human T cell rearranging V gamma gene locus. EMBO J 1987;6:1945-50.
26. Oettinger MA, Schatz DG, Gorka C, et al. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990;248:1517-23.
27. Notarangelo LD, Santagala S, Villa A. Recombinase activating gene enzymes of lymphocytes. Curr Opin Haematol 2001;8:41-6.
28. Landau NR, Schatz DG, Rosa M, et al. Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol Cell Biol 1987;7:3237-43.
29. Early P, Huang H, Davis M, et al. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell 1980;19:981-2.
30. Tonegawa S. Somatic generation of antibody diversity. Nature 1983;302:575-81.
31. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988;334:395-402.
32. Lewis SM. P nucleotides, hairpin DNA and V(D)J joining: making the connection. Semin Immunol 1994;6:131-41.
33. Nadel B, Feeney AJ. Nucleotide deletion and P addition in V(D)J recombination: a determinant role of the coding-end sequence. Mo Cell Biol 1997;17:3768-78.
34. Alt FW, Baltimore D. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc Natl Acad Sci U S A 1982;79:4118-22.
35. Gilfillan S, Dierich A, Lemeur M, et al. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 1993;261:1175-8.
36. Jorgensen JL, Esser U, Fazekas de St Groth B, et al. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992;355:224-30.
37. Akolkar PN, Gulwani-Akolkar B, Pergolizzi R, et al. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol 1993;150:2761-73.
38. Gulwani-Akolkar B, Shi B, Akolkar PN, et al. Do HLA genes play a prominent role in determining T cell receptor V alpha segment usage in humans? J Immunol 1995;154:3843-51.
39. Walser-Kuntz DR, Weyand CM, Fulbright JW, et al. HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells. Hum Immunol 1995;44:203-9.
40. Kay RA, Snowden N, Hajeer A, et al. Genetic control of the human V beta 13.2 T cell repertoire: importance of allelic variation outside the coding regions of the TCRBV13S2 gene. Eur J Immunol 1994;24:2863-7.
41. Vissinga CS, Charmley P, Concannon P. Influence of coding region polymorphism on the peripheral expression of a human TCR V beta gene. J Immunol 1994;152:1222-7.
42. Reyburn H, Cornelis F, Russell V, et al. Allelic polymorphism of human T-cell receptor V alpha gene segments. Immunogenetics 1993;38:287-91.
43. Robinson MA. Allelic sequence variations in the hypervariable region of a T-cell receptor beta chain: correlation with restriction fragment length polymorphism in human families and populations. Proc Natl Acad Sci U S A 1989;86:9422-6.
44. Li Y, Szabo P, Robinson MA, et al. Allelic variations in the human T cell receptor V beta 6.7 gene products. J Exp Med 1990;171:221-30.
45. Pile K, Wordsworth P, Liote F, et al. Analysis of a T-cell receptor V beta segment implicated in susceptibility to rheumatoid arthritis: V beta 2 germline polymorphism does not encode susceptibility. Ann Rheum Dis 1993;52:891-4.
46. Gomolka M, Epplen C, Buitkamp J, et al. Novel members and germline polymorphisms in the human T-cell receptor Vb6 family. Immunogenetics 1993;37:257-65.
47. Posnett DN, Vissinga CS, Pambuccian C, et al. Level of human TCRBV3S1 (V beta 3) expression correlates with allelic polymorphism in the spacer region of the recombination signal sequence. J Exp Med 1994;179:1707-11.
48. Ishihara S, Okada S, Wakiguchi H, et al. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 1997;54:276-81.
49. Soudeyns H, Campi G, Rizzardi GP, et al. Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood 2000;95:1743-51.
50. Pantaleo G, Demarest JF, Soudeyns H, et al. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994;370:463-7.
51. Wang EC, Moss PA, Frodsham P, et al. CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol 1995;155:5046-56.
52. Lehner PJ, Wang EC, Moss PA, et al. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 1995;181:79-91.
53. Choi YW, Kotzin B, Herron L, et al. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A 1989;86:8941-5.
54. Ulrich RG. Evolving superantigens of Staphylococcus aureus. FEMS Immunol Med Microbiol 2000;27:1-7.
55. McCormick JK, Pragman AA, Stolpa JC, et al. Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect Immun 2001;69:1381-8.
56. Bernal A, Proft T, Fraser JD, et al. Superantigens in human disease. J Clin Immunol 1999;19:149-57.
57. Ishii E, Kimura N, Kato K, et al. Clonal change of infiltrating T-cells in children with familial hemophagocytic lymphohistiocytosis: possible association with Epstein-Barr virus infection. Cancer 1999;85:1636-43.
58. Islam SA, Hay CM, Hartman KE, et al. Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression. J Virol 2001;75:4907-11.
59. Than S, Kharbanda M, Chitnis V, et al. Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children. J Immunol 1999;162:3680-6.
60. Posnett DN, Sinha R, Kabak S, et al. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994;179:609-18.
61. Schwab R, Szabo P, Manavalan JS, et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997;158:4493-9.
62. Davey MP, Burgoine GA, Woody CN. TCRB clonotypes are present in CD4+ T cell populations prepared directly from rheumatoid synovium. Hum Immunol 1997;55:11-21.
63. Michalowska-Wender G. The early stage of multiple sclerosis in the light of molecular and immunological studies. Folia Neuropathol 1999;37:273-6.
64. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993;362:68-70.
65. Ben Nun A, Liblau RS, Cohen L, et al. Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci U S A 1991;88:2466-70.
66. Sander CA, Medeiros LJ, Weiss LM, et al. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 1992;16:1170-82.
67. Elenitoba-Johnson KS, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997;14:35-47.
68. Brooks EG, Filipovich AH, Padgett JW, et al. T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly. Blood 1999;93:242-50.
69. van den Beemd R, Boor PP, van Lochem EG, et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000;40:336-45.
70. Langerak AW, van den Beemd R, Wolvers-Tettero IL, et al. Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood 2001;98:165-73.
71. Slack DN, McCarthy KP, Wiedemanm LM, et al. Evaluation of sensitivity, specificity, and reproducibility of an optimised method for detecting clonal rearrangements of immunoglobulin and T cell receptor genes in formalin fixed, paraffin embedded sections. Diagn Mol Pathol 1993;2:223-32.
72. Pannetier C, Even J, Kourilisky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-81.
73. Rosenberg WM, Moss PA, Bell JI. Variation in human T cell receptor V beta and J beta repertoire analysis using anchor polymerase chain reaction. Eur J Immunol 1992;22:541-9.
74. Uematsu Y, Wege H, Straus A, et al. The T-cell receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal. Proc Natl Acad Sci U S A 1991;19:8534-8.
75. Gagne K, Brouard S, Giral M, et al. Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts. J Immunol 2000;164:1553-63.
76. McCarthy KP, Sloan JP, Kabarowski JHS, et al. A simplified method of detection of clonal rearrangements of the T-cell receptor γ chain gene. Diagn Mol Pathol 1992;1:173-9.
77. van Dongen JJM, Wolvers-Tettero LM. Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 1991;198:93-174.
78. Bartram CR. Molecular genetic techniques for detection of minimal residual disease in acute lymphoblastic leukemia: possibilities and limitations. Recent Results Cancer Res 1993;131:149-55.
79. Kneba M, Boilz I, Linke B, et al. Analysis of rearranged T-cell receptor beta-chains by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis. Blood 1995;86:3930-7.
80. Assaf C, Hummel M, Dippel E, et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferation by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000;95:640-6.
81. Even J, Lim A, Puisieux I, et al. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol 1995;146:65-80.
82. Marguerie C, Lunardi C, So A. PCR-based analysis of the TCR repertoire in human autoimmune diseases. Immunol Today 1992;13:336-8.
83. Martinelli G, Farabegoli P, Testoni N, et al. Detection of clonality by heteroduplex analysis of amplified junctional region of T-cell receptor gamma in patients with T-cell acute lymphoblastic leukemias. Haematologica 1997;82:161-5.
84. Langerak AW, Szczepanski T, van der Burg M, et al. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997;11:2192-9.
85. Yamamoto K, Masuko-Hongo K, Tanaka A, et al. Establishment and application of a novel T cell clonality analysis using single-strand conformation polymorphism of T cell receptor messenger signals. Hum Immunol 1996;48:23-31.
86. Offermans MT, Sonneveld RD, Bakker E, et al. Denaturing and non-denaturing gel electrophoresis as methods for the detection of junctional diversity in rearranged T cell receptor sequences. J Immunol Methods 1995;181:101-14.
87. Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994;103:34-41.
88. Wilson KB, Quayle AJ, Suleyman S, et al. Heterogeneity of the TCR repertoire in synovial fluid T lymphocytes responding to BCG in a patient with early rheumatoid arthritis. Scand J Immunol 1993;38:102-12.
89. Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat 1994;3:83-94.
90. Griesser H. Gene rearrangements and chromosomal translocations in T cell lymphoma - diagnostic applications and their limits. Virchows Arch 1995;426:323-38.
91. Terhune MH, Cooper KD. Gene rearrangements and T-cell lymphomas. Arch Dermatol 1993;129:1484-90.
92. Weiss LM, Wood GS, Ellisen LW, et al. Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease). Am J Pathol 1987;126:417-21.
93. Wood GS, Strickler JG, Abel EA, et al. Immunohistology of pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. Evidence for their interrelationship with lymphomatoid papulosis. J Am Acad Dermatol 1987;16:559-70.
94. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
95. Gill JI, Gulley MD. Immunoglobulin and T cell receptor gene rearrangement. Diagn Haematol 1994;8:751-70.
96. Smith JL, Hodges E, Quin CT, et al. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000;156:661-9.
97. Lipford EH, Smith HR, Pittaluga S, et al. Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J Clin Invest 1987;79:637-42.
98. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995;85:1416-34.
99. Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res 1996;6:986-94.
100. Holland PM, Abramson RD, Watson R, et al. Detection of specific polymerase chain reaction product by utilizing the 5′→3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276-80.
101. Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific Taqman probes. Leukemia 1998;12:2006-14.
102. Bolufer P, Sanz GF, Barragan E, et al. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes. Haematologica 2000;85:1248-54.
103. Loughran TP, Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
104. Loughran TP. Large granular lymphocytic leukemia: an overview. Hosp Pract (Off Ed) 1998;33:133-8.
105. Kelly A, Richards SJ, Sivakumaran M, et al. Clonality of CD3 negative large granular lymphocyte proliferations determined by PCR based X-inactivation studies. J Clin Pathol 1994;47:399-404.
106. Akashi K, Mizuno S. Epstein-Barr virus infected natural killer cell leukemia. Leuk Lymphoma 2000;40:57-66.
107. Wack A, Cossarizza A, Heltai S, et al. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol 1998;10:1281-8.
108. Fitzgerald JE, Ricalton NS, Meyer AC, et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995;154:3538-47.
109. Hingorani R, Choi IH, Akolkar P, et al. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol 1993;151:5762-9.
110. Lamy T, Loughran TP. Current concepts: large granular lymphocytic leukaemia. Blood Rev 1999;13:230-40.
111. Martin MP, Biggar RJ, Hamlin-Green G, et al. Large granular lymphocytosis in a patient infected with HTLV-II. AIDS Res Hum Retroviruses 1993;9:715-19.
112. Choi YW, Herman A, DiGiusto D, et al. Residues of the variable regian of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature 1990;346:471-3.
113. Lechner F, Cuero AL, Kantzanou M, et al. Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers. Rev Med Virol 2001;11:11-22.
114. Wang LC, Lu MY, Yu Y, et al. T cell lymphoproliferative disorder following bone marrow transplantation for sever aplastic anaemia. Bone Marrow Transplant 2000;26:893-7.
115. Hodara VL, Jeddi-Tehrani M, Grunewald J, et al. HIV infection leads to differential expression of T-cell receptor V beta genes in CD4+ and CD8+ T cells. AIDS 1993;7:633-8.
116. Bansal AS, Green LM, Khoo SH, et al. HIV induces deletion of T cell receptor variable gene product-specific T cells. Clin Exp Immunol 1993;94:17-20.
117. Smith PR, Cavenagh JD, Milne T, et al. Benign monoclonal expansion of CD8+ lymphocytes in HIV infection. J Clin Pathol 2000;53:177-81.
118. Gorochov G, Neumann AU, Parizot C, et al. Down-regulation of CD8+ T-cell expansions in patients with human immunodeficiency virus infection receiving highly active combination therapy. Blood 2001;97:1787-95.
119. Signorini S, Imberti L, Pirovano S, et al. Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome. Blood 1999;94:3468-78.
120. Santagata S, Gomez CA, Sobacchi C, et al. N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a Fundamental role in vivo for the N-terminal domains. Proc Natl Acad Sci U S A 2000;97:14572-7.
121. Villa A, Santagata S, Bozzi F, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998;93:885-96.
122. Wade T, Takei K, Kudo M, et al. Characterisation of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders. Clin Exp Immunol 2000;119:148-55.
123. Villa A, Sobacchi C, Notarangelo LD, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood 2001;97:81-8.
124. Katial RK, Lieberman MM, Muehlbauer SL, et al. Gamma delta T lymphocytosis associated with common variable immunodeficiency. J Clin Immunol 1997;17:34-42.
125. Duchmann R, Jaffe J, Ehrhardt R, et al. Differential usage of T-cell receptor V beta gene families by CD4+ and CD8+ T cells in patients with CD8hi common variable immunodeficiency: evidence of a post-thymic effect. Immunology 1996;87:99-107.
126. Mechanic LJ, Dikman S, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997;127:613-17.
127. Cottier H, Kraft R, Meister F. Primary immunodeficiency syndromes and their manifestations in lymph nodes. Curr Top Pathol 1991;84:81-155.
128. Gottesman SR, Haas D, Ladanyi M, et al. Peripheral T cell lymphoma in a patient with common variable immunodeficiency disease: case report and literature review. Leuk Lymphoma 1999;32:589-95.
129. Schmidt D, Martens PB, Weyand CM, et al. The repertoire of CD4+. Mol Med 1996;2:608-18.
130. Goronzy JJ, Bartz-Bazzanella P, Hu W, et al. Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest 1994;94:2068-76.
131. Wucherpfennig KW, Hafler DA. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. Ann N Y Acad Sci 1995;756:241-58.
132. Babbe H, Roers A, Waisman A, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000;192:393-404.
133. Shimonkevitz R, Colburn C, Burnham JA, et al. Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis. Proc Natl Acad Sci U S A 1993;90:923-7.
134. Moreland JW, Morgan EE, Adamson TC, 3rd. et al. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum 1998;41:1919-29.
135. Umibe T, Kita Y, Nakao A, et al. Clonal expansion of T cells infiltrating the airways of non-atopic asthmatics. Clin Exp Immunol 2000;119:390-7.
136. Hodges E, Dasmahapatra J, Smith JL, et al. T cell receptor (TCR) Vbeta gene usage in bronchoalveolar lavage and peripheral blood T cells from asthmatic and normal subjects. Clin Exp Immunol 1998;112:363-74.
137. Bakakos P, Smith JL, Warner JO, et al. Modification of T-cell receptor Vbeta repertoire in response to allergen stimulation in peanut allergy. J Allergy Clin Immunol 2001;107:1089-94. system. Immunogenetics 1995;42:451-3.
138. Bakakos P, Smith JL, Warner JO, et al. Modification of T-cell receptor Vbeta repertoire in response to allergen stimulation in peanut allergy. J Allergy Clin Immunol 2001;107:1089-94. system. Immunogenetics 1995;42:451-3.
139. Van Dongen JJM, Langerak AW, San Miguel JF, et al. PCR-based clonality studies for early diagnosis of lymphoproliferative disorders: report of the BIOMED-2 concerted action [abstract]. Blood 2001;98:129a.